FrancophonIA/ELRC3.0 huggingface dataset:
English: - In the subset of patients with genotype 1 infection and low viral load (< 600,000 IU/ml) who become HCV-RNA negative at treatment week 4 and remain HCV-RNA negative at week 24, the treatment could either be stopped after this 24 week treatment course or pursued for an additional 24 weeks (i.e. overall 48 weeks treatment duration).
Danish: - I undergruppen af patienter med genotype 1 og lav virusmængde (< 600.000 IE/ml), som bliver hcv-RNA-negative ved behandlingsuge 4, og som stadig er hcv-RNA negative ved uge 24, kan behandlingen enten stoppes efter denne 24 ugers behandlingsperiode eller fortsættes i yderligere 24 uger (dvs. en samlet 48 ugers behandlingsperiode).
English: Before reconstitution, this medicine may appear either as a white tablet-shaped solid that is whole or in pieces, or as a white powder.
Danish: Færdigtilberedning af ViraferonPeg pulver til injektionsvæske Før færdigtilberedning vil dette lægemiddel være et hvidt, tabletformet fast stof, der kan være i et eller flere stykker, eller som et hvidt pulver.
English: - pulmonary fibrosis (scarring of the lungs).
Danish: - lungefibrose (dannelse af arvæv i lungerne).
English: Eleven percent of subjects (5/46) treated for 24 weeks and 13 % of subjects (6/48) treated for 48 weeks were observed to have a decrease from pre-treatment baseline of > 30 height-for-age percentiles to the end of the 5 year long-term follow-up.
Danish: Hos 11 % (5/46) af de børn, der blev behandlet i 24 uger og hos 13 % (6/48) af de børn, der blev behandlet i 48 uger, var der en reduktion i højden fra baseline før behandling til afslutningen af den 5-årige langtidsopfølgning på > 30 percentiler for alderen.
English: It is recommended that children and adolescent patients receiving ViraferonPeg/ribavirin combination be discontinued from therapy if their week 12 HCV-RNA dropped < 2 log10 compared to pretreatment or if they have detectable HCV-RNA at treatment week 24.
Danish: Det anbefales, at behandling af børn og unge patienter, der får ViraferonPeg/ribavirin i kombination, afbrydes, hvis deres uge 12 hcv-RNA falder < 2 log10 i forhold til før behandlingen, eller hvis de har detekterbar hcv-RNA i behandlingsuge 24.
English: Use the reconstituted solution (solution you prepared by adding water for injection to the ViraferonPeg powder) immediately or within 24 hours when stored in a refrigerator (2°C - 8°C).
Danish: Anvend den færdigt blandede opløsning (den opløsning, du forberedte ved tilsætning af vand til injektion til ViraferonPeg pulver) straks eller inden for 24 timer ved opbevaring i køleskab (2 °C - 8 °C).
English: Cerebrovascular haemorrhage, cerebrovascular ischaemia, encephalopathy
Danish: Cerebrovaskulær blødning, cerebrovaskulær iskæmi, encefalopati
English: After reconstitution, use the reconstituted solution immediately or within 24 hours when stored in a refrigerator (2°C - 8°C).
Danish: Efter færdigtilberedning skal den tilberedte opløsning anvendes umiddelbart eller inden for 24 timer ved opbevaring i køleskab (2 °C - 8 °C).
English: Interferon alfa-2b has been shown to be an abortifacient in primates.
Danish: Interferon alfa-2b har vist sig at være abortfremkaldende hos primater.
English: Take the short needle and place it firmly on to the tip of the syringe.
Danish: Tag den korte kanyle og sæt den fast på spidsen af sprøjten.
English: Cough, epistaxis, pharyngolaryngeal pain
Danish: Hoste, epistaxis, faryngeale smerter
English: Remove the syringe from the long needle leaving the needle in the vial and without touching the tip of the syringe.
Danish: Fjern sprøjten fra den lange kanyle, efterlad kanylen i hætteglasset uden at røre spidsen af sprøjten.
English: ViraferonPeg (1.5 µg/kg/ week) + ribavirin (800 mg)
Danish: ViraferonPeg (1,5 µg/kg/ uge) + ribavirin (800 mg)
English: Haematological abnormalities in HCV/HIV co-infected patients HCV/HIV co-infected patients receiving peginterferon alfa-2b/ribavirin treatment and HAART may be at increased risk to develop haematological abnormalities (as neutropenia, thrombocytopenia and anaemia) compared to HCV mono-infected patients.
Danish: Hæmatologiske anomalier hos hcv/hiv co-inficerede patienter Patienter, der samtidig er inficeret med hcv/hiv, og som får peginterferon alfa-2b/ribavirin- behandling og HAART, kan have øget risiko for at udvikle hæmatologiske anomalier (som neutropeni, trombocytopeni og anæmi) sammenlignet med hcv mono-inficerede patienter.
English: - Stand the vial upright and let any bubbles present in the solution rise to the top of the solution.
Danish: - Stil hætteglasset fra dig og lad alle boblerne i opløsningen stige op til overfladen.
English: - Remove the syringe from the wrapping and do not touch the tip of the syringe.
Danish: - Tag sprøjten ud af emballagen og rør ikke ved spidsen af sprøjten.
English: ViraferonPeg combination therapy (bitherapy or tritherapy) Bitherapy (ViraferonPeg with ribavirin): applies to all adult and paediatric patients 3 years of age and older.
Danish: ViraferonPeg kombinationsbehandling (2-stofs- eller 3-stofsbehandling) 2-stofsbehandling (ViraferonPeg med ribavirin): Kan anvendes til alle voksne og pædiatriske patienter i alderen tre år og ældre.
English: Other medicines and ViraferonPeg Please tell your doctor or pharmacist if you, or the child you are caring for: - are taking or have recently taken any other medicines or vitamins/nutritional supplements, including medicines obtained without a prescription.
Danish: Brug af anden medicin sammen med ViraferonPeg Fortæl det altid til lægen eller på apoteket, hvis du eller barnet, du har ansvar for: - bruger anden eller for nylig har taget medicin eller vitaminer/kosttilskud.
English: ViraferonPeg monotherapy dose reduction guidelines in adults
Danish: ViraferonPeg monoterapi vejledninger for dosisreduktion hos voksne
English: Hypothyroidism, hyperthyroidism Metabolism and nutrition disorders Very common:
Danish: Hypotyroidisme, hypertyroidisme Metabolisme og ernæring Meget almindelig:
English: Solvent for ViraferonPeg Water for injections
Danish: Solvens til ViraferonPeg Vand til injektionsvæsker
English: Please refer to the respective SmPCs of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with ViraferonPeg in combination with ribavirin.
Danish: For de antiretrovirale lægemidler, der skal tages samtidig med hcv-behandling, henvises der til disses respektive SPCer for kendskab og håndtering af toksicitet, der er specifik for det enkelte produkt samt potentialet for overlappende toksiciteter med ViraferonPeg i kombination med ribavirin.
English: Use the reconstituted solution (solution you prepared by mixing the powder and the liquid in the prefilled pen) immediately or within 24 hours when stored in a refrigerator (2°C - 8°C).
Danish: Anvend den færdigt blandede opløsning (den opløsning du tilberedte ved at mikse pulveret og væsken i pennen) straks eller inden for 24 timer ved opbevaring i køleskab (2°C - 8°C).
English: All subjects HCV 2  600,000 IU/ml > 600,000 IU/ml HCV 3  600,000 IU/ml > 600,000 IU/ml
Danish: Alle patienter hcv 2  600.000 IE/ml > 600.000 IE/ml hcv 3
English: In a non-comparative trial, 235 patients with genotype 1 and low viral load (< 600,000 IU/ml) received ViraferonPeg, 1.5 micrograms/kg subcutaneously, once weekly, in combination with weight adjusted ribavirin.
Danish: I et ikke-komparativt studie fik 235 patienter med genotype 1 og lav virusbelastning (< 600.000 IE/ml) ViraferonPeg 1,5 mikrogram/kg subkutant en gang ugentlig i kombination med vægtjusteret ribavarin.
English: Amenorrhoea, breast pain, menorrhagia, menstrual disorder, ovarian disorder, vaginal disorder, sexual dysfunction, prostatitis, erectile dysfunction
Danish: Amenorré, brystsmerter, menoragi, menstruationsforstyrrelser, ovarieforstyrrelser, vaginale gener, seksuel dysfunktion, prostatitis, erektil dysfunktion
English: Adults - Duration of treatment - Retreatment Tritherapy: Refer to the SmPC for boceprevir.
Danish: Voksne - Behandlingsvarighed - Genbehandling 3-stofsbehandling: Se SPC for boceprevir.
English: Aggression, agitation, anger, mood altered, abnormal behaviour, nervousness, sleep disorder, libido decreased, apathy, abnormal dreams, crying
Danish: Aggression, agitation, vrede, humørændring, unormal adfærd, nervøsitet, søvnforstyrrelser, nedsat libido, apati, unormale drømme, gråd
English: Patients were randomized to receive either ViraferonPeg (100 or 150 µg/week based on weight) plus ribavirin (800-1,200 mg/day based on weight) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800-1,200 mg/day based on weight).
Danish: Patienterne blev randomiseret til enten at modtage ViraferonPeg (100 eller 150 μg/uge baseret på vægt) plus ribavirin (800-1.200 mg/dag baseret på vægt) eller interferon alfa-2b (3 MIE TIW) plus ribavirin (8001.200 mg/dag baseret på vægt).
English: Adults - Duration of treatment - Naïve patients Tritherapy: Refer to the SmPC for boceprevir.
Danish: Voksne - Behandlingsvarighed - Behandlingsnaive patienter 3-stofsbehandling: Se SPC for boceprevir.
English: - Take the long needle and place it firmly on to the tip of the syringe.
Danish: - Tag den lange kanyle og sæt den fast på spidsen af sprøjten.
English: Co-administration of thioridazine with the product (ViraferonPeg) may increase the blood concentrations of thioridazine.
Danish: Samtidig administration af thioridazin og ViraferonPeg kan øge koncentrationen af thioridazin i blodet.
English: 9/l, and < 0.75 x 10
Danish: 9/l, og < 0,75 x 10
English: Do not use if it is discoloured or if particles are present.
Danish: Må ikke anvendes, hvis den er misfarvet, eller hvis der er partikler tilstede.
English: Please refer to the respective SmPCs of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with ViraferonPeg and ribavirin.
Danish: For de antiretrovirale lægemidler, der skal tages samtidig med hcv-behandling, henvises der til disses respektive SPCer for kendskab og håndtering af toksicitet, der er specifik for det enkelte produkt samt potentialet for overlappende toksiciteter med ViraferonPeg og ribavirin.
English: Ocular changes
Danish: Øjenforandringer
English: The following instructions explain how to use the pre-filled pen to inject yourself.
Danish: Følgende vejledning forklarer, hvordan du giver dig selv en indsprøjtning med den fyldte pen.
English: For HCV/HIV co-infected patients receiving ViraferonPeg in combination with ribavirin, other undesirable effects (that were not reported in mono-infected patients) which have been reported in the larger studies with a frequency > 5 % were: oral candidiasis (14 %), lipodystrophy acquired (13 %), CD4 lymphocytes decreased (8 %), appetite decreased (8 %), gamma-glutamyltransferase increased (9 %), back pain (5 %), blood amylase increased (6 %), blood lactic acid increased (5 %), cytolytic hepatitis (6 %), lipase increased (6 %) and pain in limb (6 %).
Danish: Bivirkninger, der blev rapporteret i de større studier med en hyppighed > 5 %, var oral candidiasis (14 %), erhvervet lipodystrofi (13 %), nedsatte CD4-lymfocytter (8 %), nedsat appetit (8 %), forhøjet gammaglutamyltransferase (9 %), rygsmerter (5 %), forhøjet amylase i blodet (6 %), forhøjet mælkesyre i blodet (5 %), cytolytisk hepatitis (6 %), øget lipase (6 %) og smerter i lemmerne (6 %).
English: Interferon alfa-2b (3 MIU TIW) + ribavirin
Danish: Interferon alfa-2b (3 MIE TIW) + ribavirin
English: Using a sterilised injection syringe and injection needle, 0.7 ml of water for injections is injected into the vial of ViraferonPeg.
Danish: Ved hjælp af en steril injektionssprøjte og kanyle injiceres 0,7 ml vand til injektionsvæsker, i hætteglasset med ViraferonPeg.
English: I p = 0.0143 P 1.5/R vs. I/R
Danish: = 0,0143 P 1,5/R mod I/R
English: delusions, hallucination, - hypersensitivity reaction to the medication, heart attack, inflammation of the pancreas, pain in bone and diabetes mellitus, - cotton wool spots (white deposits on the retina).
Danish: hallucinationer, - overfølsomhedsreaktion overfor lægemidlet, hjerteanfald, betændelse i bugspytkirtlen, smerter i knoglerne og diabetes mellitus (sukkersyge), - nethinde-ekssudater (hvid aflejring på nethinden).
English: Immediately contact the doctor or seek emergency treatment if they display any unusual behavioural symptoms, feel depressed, or feel they want to harm themselves or others.
Danish: Pårørende til børn og unge skal straks kontakte læge eller skadestue, hvis de bemærker nogen som helst tegn på usædvanlig opførsel, depression eller aggressiv adfærd rettet mod barnet eller den unge selv eller andre.
English: 1 vial of powder, 1 ampoule of solvent
Danish: 1 hætteglas med pulver, 1 ampul med solvens
English: Number of patients Response at end of treatment Sustained response
Danish: Respons ved afslutning af behandlingen Recidiv
English: Retreated patients who fail to achieve virological response (i.e. HCV-RNA below the limits of detection) at week 12 are unlikely to become sustained virological responders after 48 weeks of therapy (see also section 5.1).
Danish: Det er ikke sandsynligt, at genbehandlede patienter, hvor det er mislykkedes at opnå virologisk respons (dvs. hcv-RNA under detektionsgrænsen) i Uge 12, vil have vedvarende virologiske reaktioner efter 48 ugers behandling (se også pkt.
English: Ophthalmologic disorders, including retinal haemorrhages, retinal exudates, serous retinal detachment, and retinal artery or vein occlusion have been reported in rare instances after treatment with alpha interferons (see section 4.8).
Danish: Oftalmologiske forstyrrelser, inklusive nethindehæmoragi, nethinde-ekssudater, serøs nethindeløsning og retinal arterie- eller veneokklusion er blevet rapporteret i sjældne tilfælde efter behandling med alfa interferoner (se pkt.
English: 9/l (adults) ≥ 50 x 10
Danish: 9/l (voksne) < 50 x 10
English: For weight, pre-treatment to end of long-term follow-up, weightfor-age percentiles decreased 1.3 and 5.5 percentiles among subjects treated for 24 weeks or 48 weeks, respectively.
Danish: Med hensyn til vægten var der en reduktion i vægten for alderen fra før behandling til afslutning af langtidsopfølgningen på henholdsvis 1,3 og 5,5 percentiler hos de børn, der var blevet behandlet i 24 eller 48 uger.
English: Table 10 Virologic response at end of treatment, Sustained Virologic Response and relapse by HCV Genotype and viral load* ViraferonPeg 1.5 g/kg once weekly plus Ribavirin 800-1,400 mg/day End of treatment response
Danish: Tabel 10 Virologisk respons ved afsluttet behandling, vedvarende virologisk respons og tilbagefald efter hcv-Genotype og virusmængde* ViraferonPeg 1,5 g/kg en gang ugentlig plus Ribavirin 8001.400 mg/dag
English: - Patients with detectable but ≥ 2 log decrease in HCV-RNA level from baseline at treatment week 12 should be reassessed at treatment week 24 and, if HCV-RNA is undetectable, they should continue with full course of therapy (i.e. a total of 48 weeks).
Danish: - Patienter med detekterbar, men ≥ 2 log fald i hcv-RNA-niveau fra baseline ved behandlings uge 12, bør revurderes ved behandlingsuge 24, og hvis hcv-RNA ikke er målbart, bør de fortsætte hele behandlingsforløbet (dvs. i alt 48 uger).
English: Disposal of the injection materials
Danish: Bortskaffelse af materiale
English: Alanine aminotransferase (ALT)
Danish: Alaninaminotransferase (ALAT)
English: Co-administration of theophylline with the product (ViraferonPeg) may increase the blood concentrations of theophylline.
Danish: Samtidig administration af theophyllin og ViraferonPeg kan øge koncentrationen af theophyllin i blodet.
English: All patients should have a baseline eye examination.
Danish: Alle patienter bør have foretaget en øjenundersøgelse ved behandlingens start.
English: Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, 4.2).
Danish: Lægemidlet må kun udleveres efter ordination på en recept udstedt af en begrænset lægegruppe (se bilag I: Produktresumé, pkt.
English: Please refer to the ribavirin SmPC when ViraferonPeg is to be used in combination with ribavirin.
Danish: Se SPC for ribavirin, når ViraferonPeg skal bruges i kombination med ribavirin.
English: Please refer to the ribavirin and boceprevir Summary of Product Characteristics (SmPCs) when ViraferonPeg is to be used in combination with these medicines.
Danish: Se produktresumeer (SPC'er) for ribavirin og boceprevir, når ViraferonPeg skal bruges i kombination med disse lægemidler.
English: Female: Dysmenorrhoea
Danish: Hos kvinder: Dysmenoré
English: • Support the pre-filled pen in upright position and push the needle straight down firmly (see Figure 6).
Danish: • Hold den fyldte pen opad og tryk kanylen lige ned med et fast tryk (se Figur 6).
English: The decision to treat should be made on a case by case basis (see section 4.4).
Danish: Beslutningen om at behandle bør tages individuelt fra patient til patient (se pkt.
English: Patients with creatinine clearance < 50 ml/minute must not be treated with ViraferonPeg in combination with ribavirin (bitherapy or tritherapy) (see section 4.3).
Danish: Patienter med kreatininclearance < 50 ml/minut må ikke behandles med ViraferonPeg i kombination med ribavirin (2-stofs- eller 3-stofsbehandling) (se pkt.
English: ViraferonPeg in combination with ribavirin (bitherapy) is indicated for the treatment of CHC infection in adult patients who are previously untreated including patients with clinically stable HIV co-infection and in adult patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated) and ribavirin combination therapy or interferon alpha monotherapy (see section 5.1).
Danish: ViraferonPeg i kombination med ribavirin (2-stofsbehandling) er indiceret til behandling af CHCinfektion hos voksne patienter, der ikke tidligere har været i behandling, inklusive patienter med klinisk stabil hiv-co-infektion, og til voksne patienter, hvor tidligere kombinationsbehandling med interferon alfa (pegyleret eller non-pegyleret) plus ribavirin eller interferon alfa monoterapi er mislykkedes (se pkt.
English: If renal function decreases during treatment, ViraferonPeg therapy should be discontinued.
Danish: Hvis nyrefunktionen nedsættes under behandling, bør ViraferonPeg behandlingen seponeres.
English: Growth and development (children and adolescents) During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years, weight loss and growth inhibition were common.
Danish: Under behandlingsforløbet, der varede op til 48 uger hos patienter i alderen 3 til 17 år, var vægttab og væksthæmning almindelig.
English: The dose of ViraferonPeg for monotherapy should be reduced in patients with moderate or severe renal impairment
Danish: Dosen af ViraferonPeg i monoterapi bør reduceres hos patienter med moderat eller stærkt nedsat nyrefunktion (se pkt.
English: nd dose reduction of ViraferonPeg is to 20 g/m 2/week.
Danish: ViraferonPeg er til 20 μg/m 2/uge.
English: Interferon alfa-2b (3 MIU TIW) + ribavirin (800 mg)
Danish: Interferon alfa-2b (3 MIE TIW) + ribavirin (800 mg)
English: Please refer to the ribavirin SmPC for capsules or oral solution when ViraferonPeg is to be used in combination with ribavirin.
Danish: Se SPC for ribavirin kapsler eller oral opløsning, når ViraferonPeg skal anvendes i kombination med ribavirin.
English: Amnesia, memory impairment, syncope, migraine, ataxia, confusion, neuralgia, paraesthesia, hypoaesthesia, hyperaesthesia, hypertonia, somnolence, disturbance in attention, tremor, dysgeusia
Danish: Amnesi, svigtende hukommelse, synkope, migræne, ataksi, forvirring, neuralgi, paræstesi, hypoæstesi, hyperæstesi, hypertoni, døsighed, opmærksomhedsforstyrrelser, tremor, smagsforstyrrelser
English: Response week 12 was defined as undetectable HCVRNA after 12 weeks of treatment.
Danish: 12 ugers respons på behandlingen blev defineret som ikke målbart hcv-RNA efter 12 ugers behandling.
English: Response at end of treatment 49 % 41 % 33 % 24 % 65 % 56 % 54 % Sustained response
Danish: Vedvarende respons 23 %* 25 % 18 % 12 % 54 %** 47 % 47 %
English: SN: NN
Danish: PC: SN: NN:
English: Ophthalmological disorders that have been reported rarely with alpha interferons include retinopathies (including macular oedema), retinal haemorrhages, retinal artery or vein occlusion, retinal exudates, loss of visual acuity or visual field, optic neuritis, and papilloedema (see section 4.4).
Danish: Oftalmologiske lidelser, der er rapporteret sjældent med alfa interferoner, omfatter retinopatier (inklusive makuløst ødem), nethindehæmoragier, arterie- eller veneokklusion i nethinden, retinalt ekssudat, nedsat visuel skarphed eller synsfelt, optisk neuritis og papilødem (se pkt.
English: Monotherapy with ViraferonPeg and bitherapy with ViraferonPeg and ribavirin Naïve patients
Danish: Monoterapi med ViraferonPeg og 2-stofsbehandling med ViraferonPeg og ribavirin Behandlingsnaive patienter
English: Dose of peginterferon alfa-2b
Danish: Peginterferon alfa-2b dosis
English: ViraferonPeg - ampoule of solvent
Danish: ViraferonPeg - ampul med solvens
English: Vomiting *, nausea, abdominal pain, diarrhoea, dry mouth*
Danish: Opkastning *, kvalme, abdominalsmerter, diaré, mundtørhed
English: Although, the majority of them could be managed by dose reduction, close monitoring of haematological parameters should be undertaken in this population of patients (see section 4.2 and below “Laboratory tests” and section 4.8).
Danish: Selvom hovedparten af dem kunne håndteres ved dosisreduktion, bør hæmatologiske parametre monitoreres tæt i denne patientpopulation (se pkt.
English: o Taking this medicine in combination with ribavirin and an anti-HIV medicine(s) may increase the risk of lactic acidosis, liver failure, and blood abnormalities: reduction in number of red blood cells, white blood cells and blood clotting cells called platelets.
Danish: o Hvis dette lægemiddel tages i kombination med ribavirin og et eller flere anti-hiv lægemiddel(ler) kan risikoen øges for mælkesyreacidose, leversvigt og udvikling af blodabnormiteter: reduktion i antallet af røde blodlegemer, hvide blodlegemer og blodkoagulerende celler kaldet blodplader.
English: If you are an HCV/HIV co-infected adult patient receiving HAART, the addition of this medicine and ribavirin may increase your risk of lactic acidosis, liver failure, and development of blood abnormalities (reduction in number of red blood cells which carry oxygen, certain white blood cells that fight infection, and blood clotting cells called platelets).
Danish: Hvis du både er inficeret med hcv og hiv og får HAART, kan brugen af dette lægemiddel sammen med ribavirin øge din risiko for mælkesyreacidose, leversvigt og bivirkninger i blodet (nedsat antal røde blodlegemer, der transporterer ilt, visse hvide blodlegemer, der bekæmper infektion, samt cellerne, som får blodet til at størkne, kaldet blodplader).
English: Your healthcare provider will instruct you how to self-inject this medicine.
Danish: En læge eller sygeplejerske vil instruere dig i, hvordan du selv indsprøjter dette lægemiddel.
English: Haemolytic anaemia, leukopenia, thrombocytopenia, lymphadenopathy
Danish: Hæmolytisk anæmi, leukopeni, trombocytopeni, lymfadenopati
English: Renal failure, renal insufficiency Reproductive system and breast disorders Common:
Danish: Nyresvigt, nedsat nyrefunktion Det reproduktive system og mammae Almindelig:
English: Add needle • Turn the dial to number 2 (see Figure 3).
Danish: Sæt kanylen på • Drej doseringsknappen til tallet 2 (se Figur 3).
English: Genotype 1  600,000 IU/ml
Danish: Genotype 1  600.000 IE/ml